2024 ICD-10-CM Diagnosis Code D09.0

Carcinoma in situ of bladder

ICD-10-CM Code:
D09.0
ICD-10 Code for:
Carcinoma in situ of bladder
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:

Code Classification

  • Neoplasms
    (C00–D49)
    • In situ neoplasms
      (D00-D09)
      • Carcinoma in situ of other and unspecified sites
        (D09)

D09.0 is a billable diagnosis code used to specify a medical diagnosis of carcinoma in situ of bladder. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic bladder (urinary) ; Neoplasm, neoplastic bladder (urinary) dome ; Neoplasm, neoplastic bladder (urinary) neck ; Neoplasm, neoplastic bladder (urinary) orifice ; Neoplasm, neoplastic bladder (urinary) orifice ureteric ; Neoplasm, neoplastic bladder (urinary) orifice urethral ; Neoplasm, neoplastic bladder (urinary) sphincter ; etc

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Cancer in situ of urinary bladder
  • Carcinoma in situ of anterior wall of urinary bladder
  • Carcinoma in situ of apex of urinary bladder
  • Carcinoma in situ of dome of urinary bladder
  • Carcinoma in situ of lateral wall of urinary bladder
  • Carcinoma in situ of posterior wall of urinary bladder
  • Carcinoma in situ of trigone of urinary bladder
  • Carcinoma in situ of urachus
  • Carcinoma in situ of ureter
  • Carcinoma in situ of ureteric orifice of urinary bladder
  • Carcinoma in situ of urinary bladder neck
  • Neoplasm of anterior wall of urinary bladder
  • Neoplasm of apex of urinary bladder
  • Neoplasm of dome of urinary bladder
  • Neoplasm of lateral wall of urinary bladder
  • Neoplasm of posterior wall of urinary bladder
  • Neoplasm of trigone of urinary bladder
  • Neoplasm of urachus
  • Neoplasm of ureteric orifice of urinary bladder
  • Neoplasm of urinary bladder neck

Clinical Classification

Clinical Information

  • Urachus

    an embryonic structure originating from the allantois. it is a canal connecting the fetal urinary bladder and the umbilicus. it is normally converted into a fibrous cord postnatally. when the canal fails to be filled and remains open (patent urachus), urine leaks through the umbilicus.

Convert D09.0 to ICD-9-CM

  • ICD-9-CM Code: 233.7 - Ca in situ bladder

Table of Neoplasms

This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »bladder (urinary)
C67.9C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »dome
C67.1C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »neck
C67.5C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »orifice
C67.9C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »orifice
      »ureteric
C67.6C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »orifice
      »urethral
C67.5C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »sphincter
C67.8C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »trigone
C67.0C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »urachus
C67.7C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »wall
C67.9C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »wall
      »anterior
C67.3C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »wall
      »lateral
C67.2C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »wall
      »posterior
C67.4C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »urachus
C67.7C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »ureter, ureteral
    »orifice (bladder)
C67.6C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »ureter-bladder (junction)
C67.6C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »urethra, urethral (gland)
    »orifice, internal
C67.5C79.11D09.0D30.3D41.4D49.4

Patient Education


Bladder Cancer

The bladder is a hollow organ in your lower abdomen that stores urine. Bladder cancer occurs in the lining of the bladder. It is the sixth most common type of cancer in the United States.

Symptoms include:

  • Blood in your urine
  • A frequent urge to urinate
  • Pain when you urinate
  • Low back pain

Risk factors for developing bladder cancer include smoking and exposure to certain chemicals in the workplace. People with a family history of bladder cancer or who are older, white, or male have a higher risk.

Treatments for bladder cancer include surgery, radiation therapy, chemotherapy, and biologic therapy. Biologic therapy boosts your body's own ability to fight cancer.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Bladder cancer

Bladder cancer is a disease in which certain cells in the bladder become abnormal and multiply uncontrollably to form a tumor. The bladder is a muscular organ in the lower abdomen that stores urine until it can be removed (excreted) from the body.

Bladder cancer may cause blood in the urine, pain during urination, frequent urination, the feeling of needing to urinate without being able to, or lower back pain. Many of these signs and symptoms are nonspecific, which means they may occur in multiple disorders. People who have one or more of these nonspecific health problems often do not have bladder cancer, but have another condition such as an infection.

Bladder cancer develops when tumors form in the tissue that lines the bladder. There are several types of bladder cancer, categorized by the type of cell in the tissue that becomes cancerous. The most common type is transitional cell carcinoma (also known as urothelial carcinoma); others include squamous cell carcinoma and adenocarcinoma. If the tumor spreads  (metastasizes) beyond the lining of the bladder into nearby tissues or organs, it is known as invasive bladder cancer. 


[Learn More in MedlinePlus]

Bladder Cancer-Patient Version

Learn about bladder cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Bladder Cancer Summary

Learn about bladder cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.